TCB Publications - Abstract

TCB Publications - Abstract

Santosh K. Misra, Goutam Ghoshal, Manas R. Gartia, Zhe Wu, Mao Ye, Corinne R. Bromfield, Emery M. Williams, Krishnarao V. Tangella, Klaus Schulten, Partha S. Ray, Everette C. Burdette, and Dipanjan Pan. Tri-Modal therapy: Combining hyperthermia with repurposed bexarotene and ultrasound for treating liver cancer. ACS Nano, 9:10695-10718, 2015. (PMC: PMC4820022)

MISR2015 Repurposing of existing cancer drugs to overcome their physical limitations, such as insolubility, represents an attractive strategy to achieve enhanced therapeutic efficacy and broaden the range of clinical applications. Such an approach also promises to offer substantial cost savings in drug development efforts. Here we use repurposed FDA- approved topical agent bexarotene (Targretin$^{TM}$), currently in limited use for cutaneous manifestations of T-cell lymphomas, and re-engineer it for use in solid tumor applications by forming self-assembling nanobubbles. Physico-chemical characterization studies of the novel prodrug nanobubbles demonstrated their stability, enhanced target cell-internalization capability and highly controlled release profile in response to application of focused ultrasound energy. Using an in vitro model of hepatocellular carcinoma and an in vivo large animal model of liver ablation, we demonstrate the effectiveness of bexarotene prodrug nanobubbles when used in conjunction with catheter- based ultrasound, thereby highlighting the therapeutic promise of this trimodal approach.

Download Full Text

The manuscripts available on our site are provided for your personal use only and may not be retransmitted or redistributed without written permissions from the paper's publisher and author. You may not upload any of this site's material to any public server, on-line service, network, or bulletin board without prior written permission from the publisher and author. You may not make copies for any commercial purpose. Reproduction or storage of materials retrieved from this web site is subject to the U.S. Copyright Act of 1976, Title 17 U.S.C.

Download full text: Request a Copy, Journal, Supplemental Material (895.6KB) - Supplemental PDF, Supplemental Material (46.3MB) - Supplemental Files